According to our latest study on “Viral Antigens Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Component [Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others], Technique [ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining,Immunofluorescence, and Others], and End User [Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes] ,”
The market was valued at US$101.41 million in 2019 and is projected to reach US$236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The report highlights the trends prevailing in the global viral antigens market, and drivers and restraints pertaining to its growth. The growth of the market is mainly attributed to the increasing prevalence of viral diseases, escalated acceptance for viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, emerging markets present significant opportunities for the players operating in the global viral antigens market.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00017334
Most of the recently established techniques, such as electron microscopy, are promising sand trigger advancements in viral research. For example, advancements in imaging systems have enabled effective and reproducible real-time image capture and immunoassay results can be obtained. In vaccine research and development, regular outbreaks of virus-induced infectious diseases, such as influenza, hepatitis, AIDS, and, more recently, COVID-19 are causing urgency. This, in turn, is expected to lead to rapid growth in the demand for viral antigens.
Image analysis software can be used to extract useful knowledge to gain new insights, and accelerate decision-making, as well as make it more assured. Effective image analysis software makes it far easier for researchers to produce and analyze image data from cellular samples and in vivo models. From 2D and 3D optical imaging to advanced microCT analysis and co-registration of data from other modalities, in vivo imaging software help capture the same, easy-to-use, scalable, high-performance, quantitative software solutions that are crucial to get significant outcomes from in vivo research. Similarly, cellular imaging and analysis tools can help collect, visualize, interpret, and exchange image information more easily and efficiently, which helps make vaccine discovery process less time-consuming.
Key Market Players:
Microbix Biosystems, BIO-RAD Laboratories INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-TanyTechnogene Ltd., ACROBiosystems., Meridian Bioscience, Inc., Rekom Biotech S.L, and LGC Limited are among the players operating in the viral antigens market. These players focus on product developments and innovation to sustain their market positions. For instance, in October 2020, Microbix Biosystems Inc. entered into an agreement with the Ontario Together Fund of the Ministry of Economic Development, Job Creation and Trade. The company received OTF grant of US$ 1.45 million to cover 50% of the cost to automate the production of Microbix’s quality assessment products that help assure the accuracy of the disease diagnostic testing, and enable local, secure, and cost-effective automated production of viral transport media required for Ontario’s nucleic acid testing projects related to COVID-19.
The report segments the global viral antigens market as follows:
- Influenza Viral Antigens
- Coronavirus Antigens
- Zika Virus Antigens
- Ebola Virus Antigens
- Dengue Virus Antigens
- Herpes Simplex Virus (HSV) Antigens
- Rotavirus Viral Antigens
- Hepatitis A-E Virus Antigens
- Measles Virus Antigens
- Mumps/Parotitis Virus Antigens
- Radioimmunoassay (RIA)
- Immunoperoxidase Staining
BIO-RAD Laboratories Inc., Meridian Bioscience, Inc. – Notable Participants in Viral Antigens Market
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
A few of the most notable companies occupying a considerable share of the market are Microbix Biosystems, BIO-RAD Laboratories INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-Tany Technogene Ltd., ACROBiosystems., Meridian Bioscience, INC., Rekom Biotech S.L, and LGC Limited.
Market leaders are involved in partnerships, product launches, acquisitions, and other strategies to improve their performance and consolidate the market position. For instance, In July LGC Group acquired The Native Antigen Company, one of the world’s leading suppliers of high-quality infectious disease antigens and antibodies, based in Oxford, UK, for consideration of £15.7m. The net assets of the acquired business were £4.8m.
Prominent players in the viral antigens market are focusing on organic strategies such as product launches, product approvals, and geographic and manufacturing expansions. These strategies help them strengthen their market positions, along with allowing them to broaden their geographic footprints.